SCHEMBL4376916

SCHEMBL4376916

COc1ccc2c(c1)c1c(n2C)C([Si](C)(C)C2c3ccccc3-c3c2n(C)c2ccc(OC)cc32)c2ccccc2-1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
MAPT P10636 5/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 5/20 0.48
HSD17B10 Q99714 4/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
HTT P42858 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NPSR1 Q6W5P4 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 2/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 2/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
APAF1 O14727 1/20 0.39
PABPC1 P11940 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383628 0.91 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL7195665 0.82 GPR3 (0.40) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL7116380 0.81 DNMT1 (0.37) ALDH1A1L3MBTL1MEN1KMT2ARAB9A
SCHEMBL7125690 0.79 GPR3 (0.38) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL4373543 0.74 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL4375945 0.74 MEN1 (0.39) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL3224020 0.71 MAPT (0.39) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL7127304 0.71 ALDH1A1 (0.32) ALDH1A1MAPTL3MBTL1NPSR1RAB9A
SCHEMBL7633752 0.69 HTT (0.35) ALDH1A1MAPTKDM4EHTTMEN1
SCHEMBL12422969 0.68 MAOA (0.39) ALDH1A1MAPTKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1533324-B1 A ligand for a metallocene catalyst used to prepare propylene based polymers, and its preparation method BASELL POLYOLEFINE GMBH (DE) 2009-05-06 EP disclosed
EP-1533324-A2 A ligand for a metallocene catalyst used to prepare propylene based polymers, and its preparation method Basell Polyolefine GmbH (DE) 2005-05-25 EP disclosed
EP-1159310-B1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS BASELL POLYOLEFINE GMBH (DE) 2005-03-30 EP disclosed
US-6730754-B2 COORDINATION POLYMERIZATION CATALYST BASELL POLYOLEFINE GMBH (DE) 2004-05-04 US disclosed
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers EQUISTAR CHEMICALS, LP 2002-10-10 US disclosed
EP-1159310-A1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS Basell Technology Company B.V. (NL) 2001-12-05 EP disclosed
WO-2001053360-A1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers GRB7, CHRM1, CPNE4 ALDH1A1 4259/4885MAPT 4312/4885KDM4E 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.